Alexandra Sowa's new book The Ozempic Revolution is intended to be the "first comprehensive user guide" to GLP-1 drugs like ...

Glucagon-like peptide-1 (GLP-1) is a hormone produced in the gut that plays a crucial role in regulating metabolism, particularly in glucose homeostasis and appetite control. It is secreted by ...

Early research suggests GLP-1 drugs could prevent or treat Alzheimer's Disease. Results from a big clinical trial could soon ...

The author of a new guidebook on GLP-1s and other experts share their tips for how clinicians can optimize patient success ...

Salk Institute researchers have identified a key protein that may help users of GLP-1 drugs such as Ozempic and Wegovy ...

A study on GLP1RA medications found that behavioral side effects likely do not result from direct action on GLP1R.

Ozempic and Wegovy do the same thing as GLP-1 would normally do for you — but to enable them to treat diabetes and obesity, ...

About one in eight adults in the United States has tried or currently uses a GLP-1 medication, and a quarter of those users ...

Patients with metabolic dysfunction-associated steotohepatitis (MASH) who are already taking a glucagon-like peptide-1 ...

Glp-1 Analogues Market OverviewThe Glp analogues market size is expected to be worth USD 606.3 billion by 2034.The target market was valued at USD 45.3 billion in 2024.The market is projected to grow ...